Therefore, the antioxidant effect of verbascoside could be regulated by increasing SIRT1 activity, leading to treatment of obesity and related metabolic disorders through AMPK activation [63]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.